Graph Therapeutics

📍 Vienna, Austria🗓 Founded 2024👥 13 employees
Biotechnology Research🌐 graphtx.com
Website LinkedIn
Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of patients are left without adequate treatment options - and AI trained with complex disease data can solve this.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Graph Therapeutics founded?
Graph Therapeutics was founded in 2024.
What industry is Graph Therapeutics in?
Graph Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Graph Therapeutics based?
Graph Therapeutics is headquartered in Vienna, Austria.